Free tool
FAERS Monitor: Celebrex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020998 or its brand name (Celebrex, Celecoxib). Reports on generic versions are filed under their own applications.
Reports
132,410
Serious
93,029
70% of reports
Hospitalization
40,922
Death reported
12,748
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective18,274
- pain12,761
- arthralgia11,408
- fatigue10,286
- nausea9,975
- off label use8,305
- drug hypersensitivity8,032
- diarrhoea7,761
- headache7,645
- rheumatoid arthritis7,585
- myocardial infarction7,052
- rash6,675
- dizziness6,604
- malaise6,572
- condition aggravated6,540
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3,673 |
| 2005 | 4,992 |
| 2006 | 4,651 |
| 2007 | 6,894 |
| 2008 | 2,482 |
| 2009 | 2,404 |
| 2010 | 6,011 |
| 2011 | 3,916 |
| 2012 | 5,869 |
| 2013 | 6,069 |
| 2014 | 6,647 |
| 2015 | 6,720 |
| 2016 | 6,777 |
| 2017 | 6,322 |
| 2018 | 6,844 |
| 2019 | 7,930 |
| 2020 | 8,497 |
| 2021 | 6,148 |
| 2022 | 6,500 |
| 2023 | 5,721 |
| 2024 | 6,578 |
| 2025 | 6,704 |
| 2026 | 4,058 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,921,749 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| rheumatoid arthritisSignal | 7,585 | 11.3 | 11.0 | 66,810 |
| drug hypersensitivitySignal | 8,032 | 6.8 | 6.7 | 38,700 |
| myocardial infarctionSignal | 7,052 | 6.6 | 6.5 | 32,743 |
| arthralgiaSignal | 11,408 | 4.5 | 4.4 | 30,304 |
| condition aggravatedSignal | 6,540 | 3.5 | 3.4 | 11,414 |
| painSignal | 12,761 | 3.3 | 3.3 | 21,201 |
| rashSignal | 6,675 | 2.5 | 2.4 | 5,785 |
| malaiseSignal | 6,572 | 2.4 | 2.3 | 5,405 |
| drug ineffectiveSignal | 18,274 | 2.2 | 2.2 | 12,880 |
| dizzinessSignal | 6,604 | 2.1 | 2.1 | 3,938 |
| fatigueSignal | 10,286 | 2.1 | 2.1 | 6,181 |
| nauseaSignal | 9,975 | 2.0 | 2.0 | 5,230 |
| headache | 7,645 | 1.9 | 1.9 | 3,593 |
| diarrhoea | 7,761 | 1.9 | 1.9 | 3,492 |
| off label use | 8,305 | 1.5 | 1.5 | 1,485 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.